Why Trump Should Be Good Medicine For The Pharma Industry

Published: Nov 16, 2016

The holidays came early for the pharmaceutical industry this year.

With Donald Trump elected to the White House and Republicans controlling Congress, the companies that make your medicines can expect a friendlier environment in which to operate. And investors quickly responded by boosting drug and biotech stocks.

So what lies ahead? Here are a few predictions:

FDA will stand for Faster Drug Approvals

Many Republicans would like to speed the Food and Drug Administration process for getting new medicines to patients. That’s going to remain a high priority.

Back to news